Linear eMerge E3-Series devices allow Command Injections.
Loading...
Loading...
Score elevated to 9.8 because this CVE is listed on the CISA Known Exploited Vulnerabilities catalog (added 2024-03-25), indicating real-world exploitation has been confirmed by US federal agencies. NVD baseline CVSS 9.8 retained for reference. Confidence: HIGH.
Linear eMerge E3-Series devices allow Command Injections.
July 2, 2019
November 6, 2025
MITRE Common Weakness Enumeration — the root-cause categories this CVE belongs to.
Every time one of our enrichment pipelines (NVD, MITRE cvelistV5, EPSS, CISA KEV, GHSA, OSV, vendor advisories) ran against this CVE. Most recent first.
Working exploit code is in the public domain (1 Metasploit module) (1 Exploit-DB entry). Defenders should treat patch urgency accordingly — public PoCs typically lead to mass-exploitation within 24-72 hours.
eMerge E3 1.00-06 - Remote Code Execution
Open source ↗Linear eMerge E3-Series Access Controller Command Injection
Open source ↗eMerge E3 1.00-06 - Remote Code Execution
Open source ↗See which npm, PyPI, Go, and Maven packages are affected by CVE-2019-7256
EchelonGraph automatically scans your cloud infrastructure and maps CVE exposure using blast radius analysis.
CWE-78